HAMPTON ROADS, Va. – Dr. Jason Luke, Director of the Cancer Immunotherapy Center at UPMC, and Kyleigh LiPira, CEO of the Melanoma Research Foundation, discuss a new treatment option for Melanoma called Opdualag, and what it may mean for patients facing the disease.
Presented by Bristol Myers Squibb.
Visit opdualag.com for more information.
